Abstract
Many urinary tract stones consist of calcium, and has high relapse rate. Accordingly, it is very important to prevent calcium-containing stone formation. This paper describes about effects and mechanisms for Xanthine oxidase inhibitor, citrate formulation, magnesium formulation, thiazides, vitamin B(6), extract of Quercus salicina Blume and chorei-to (medical herb) . Recent new drugs and the elucidation of new metabolic pathways may lead to the development of prevention of urolithiasis.
MeSH terms
-
Allopurinol / pharmacology*
-
Allopurinol / therapeutic use*
-
Animals
-
Calcium / metabolism*
-
Citrates / pharmacology
-
Citrates / therapeutic use
-
Drugs, Chinese Herbal / pharmacology
-
Drugs, Chinese Herbal / therapeutic use
-
Humans
-
Magnesium Compounds / pharmacology
-
Magnesium Compounds / therapeutic use
-
Phytotherapy
-
Plant Extracts / pharmacology
-
Plant Extracts / therapeutic use
-
Secondary Prevention
-
Sodium Chloride Symporter Inhibitors / pharmacology
-
Sodium Chloride Symporter Inhibitors / therapeutic use
-
Urinary Calculi / drug therapy*
-
Urinary Calculi / metabolism
-
Urinary Calculi / prevention & control*
-
Vitamin B 6 / pharmacology
-
Vitamin B 6 / therapeutic use
-
Xanthine Oxidase / antagonists & inhibitors
Substances
-
Citrates
-
Drugs, Chinese Herbal
-
Magnesium Compounds
-
Plant Extracts
-
Sodium Chloride Symporter Inhibitors
-
choreito
-
Allopurinol
-
Vitamin B 6
-
Xanthine Oxidase
-
Calcium